Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The Pan-FLT3/BTK Multi-kinase Inhibitor CG806 Induces AML Killing in FLT-mutant and Wild Type Cells, and Exerts Synergistic Pro-apoptotic Effects with Concomitant Targeting of Anti-apoptotic Bcl-2 and/or Mcl-1
:max_bytes(150000):strip_icc()/health-GettyImages-2025836701-ce3f5ccf0f98428e9d14abaeb07ba307.jpg)
Product Code : 2046
MariTides potential benefits include: Monthly dosing Significant weight loss Strong improvements in cardiometabolic markers A novel GIPR-blocking mechanism Extended half-life via antibody technology Early results showing improvements in blood sugar, HbA1c, and potentially blood pressure If approved, MariTide could offer a new option for millions living with obesity, type 2 diabetes, or related conditions like sleep apnea and cardiovascular disease
421,423 Interdisciplinary collaboration among clinicians, biologists, and data scientists is crucial to refine these models and translate AI-driven insights into clinical interventions
US$ 23.79
US$ 24.96
US$ 29.12
US$ 25.70
US$ 22.63
US$ 23.83
US$ 26.62
US$ 22.45
US$ 22.87
